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Abstract: The objectives of this experiment were to induce prostate atrophy by ligating prostate vessels and nerves and evaluate
the histological changes in the prostates.
Animal material consisted of 10 normal (healthy) crossbred dogs. The branches of the prostate artery, prostate veins, prostate
innervating nerves, and hypogastric and pelvic nerves were ligated and then cut for each of the dogs under general anesthesia. Three
months after surgery, the dogs were euthanased by with an overdose of sodium pentobarbital. Prostate length, depth, width and
weight were measured during surgery (induction) and after euthanasia. Two hemi-cross-sections of each prostate, the left and right
mid portions, were taken for histological examination.
There were significant differences in prostate length and weight measured during surgery and after euthanasia. In the
histopathological examination, there was a decrease in compound tubular alveolar glands for all dogs, whereas there was an increase
in fibrous tissue formation throughout the prostates.
In conclusion, although there was a statistical decrease in the mean prostate length and weight measured during surgery and after
euthanasia, this was considered to be negligible in clinical practice for reducing the size of an enlarged prostate.
Key Words: Prostate, atrophy, ligation, dog

Prostat Atrofisi Oluflturmak Amac›yla Prostat Damar ve Sinirlerinin Ligasyonu
Özet: Bu çal›flman›n amac›, prostat damar ve sinirlerini ligatüre ederek prostat›n atrofi olup olmad›¤›n› araflt›rmak ve oluflan
de¤ifliklikleri histolojik bak›da incelemekti.
Hayvan materyali 10 normal sa¤l›kl› melez köpekten olufltu. Prostat arter, venalar› ve prostat› innerve eden sinirler olan hypogastrik
ve pelvik sinirler genel anestezi alt›nda ligatüre edilerek kesildi. Postoperatif 3 ay sonra her bir köpek fazla dozda sodium penthotal
verilerek uyutuldu. Prostat›n uzunluk (L), derinlik (D), genifllik (W) ve a¤›rl›k birimleri operasyon s›ras› ve ötenazi sonras› ölçüldü.
Histopatolojik muayeneler amac›yla prostat›n sa¤ ve sol lobundan kesitler al›narak incelendi.
Operasyon s›ras› ve ötenazi sonras› ölçülen prostat boy ve a¤›rl›¤› aras›nda istatistiksel olarak önemli farkl›l›klar vard›. Histopatolojik
olarak, prostat genelinde tüm olgular için fibröz doku art›fl› gözlenirken, tubulo alveolar glandda bir azalma mevcuttu.
Sonuç olarak, operasyon s›ras› ve ötenazi sonras› saptanan ortalama prostat uzunluk ve a¤›rl›klar› aras›nda istatistiksel olarak belirgin
bir azalma saptanmas›na karfl›l›k, bunun klinik pratikte büyümüfl prostatlar› gözle görülecek derecede atrofiye dönüfltürmek için
yeterli olmayaca¤› kanaatine var›ld›.
Anahtar Sözcükler: Prostat, atrofi, ligasyon, köpek

Introduction
The prostate gland is the only accessory sex gland in
the male dog and it is a bilobed organ with a median
septum on the dorsal surface continuous with the fibrous

capsule (1). It is bounded cranially by the urinary bladder,
ventrally by the floor of the pelvis and abdominal wall,
and dorsally by the rectum, from which it is separated by
2 layers of folded peritoneum (2).
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The blood supply of the gland is provided by branches
of the prostatic artery that penetrate the prostatic
capsule on the dorsolateral surface. Venous return is
provided by the prostatic and urethral veins that connect
to the internal iliac vein (2). This vessel can be seen
readily when the adipose tissue overlying the prostate
gland has been reflected and the gland has been rotated
slightly (2).
The prostate gland is innervated by the hypogastric
and pelvic nerves. The nerve supply to the prostate is
closely parallel to the vasculature (1-3). The hypogastric
nerve follows the artery of the ductus deferens to the
prostate. The pelvic nerve follows the prostatic to the
pelvic plexus before projecting fibers to the gland (4).
Neurons from the hypogastric nerve, part of the
sympathetic nervous system, stimulate the secretory
epithelium, as well as the contractile smooth muscle (5).
The pelvic nerve provides parasympathetic cholinergic
innervation to the smooth muscle, with little influence on
the secretory epithelium (5).
Prostate diseases including benign hyperplasia,
bacterial prostatitis, cysts, abscesses and neoplasia are
commonly diagnosed in older sexually intact male dogs
(6). The prostate gland undergoes 3 distinct phases of
activity during the life of a dog. In the young adult dog
(1-5 years of age), there is a normal growth, in middle
age (6-10 years of age), hyperplasia develops, and in old
age, there is senile atrophy (7,8). Benign prostatic
hyperplasia (BPH) is a common medical problem in old
male dogs (9). The size of the prostate gland may
increase up to 4 times its normal size in a hyperplastic
prostate (9,10). The cause and pathogenesis of the
disease are not fully elucidated, but hormonal factors are
evidently involved (8,11).
Clinical signs for BPH usually involve constipation and
tenesmus or mild hemorrhage urethral discharge (12).
Treatment of dogs with BPH is aimed to reduce the size
of the gland and eliminate clinical signs related to
hyperplasia. These goals are accomplished by castration,
which causes the prostate to decrease in size over 2 to 3
months (9). In some instances, however, the owner finds
this to be an unacceptable solution. This has led
researchers to come up with alternative approaches for
the treatment of BPH, such as administration of
estrogens (13), alpha-1 adrenoceptor antagonists (14),
5-alpha reductase agents (15,16), or synthetic steroids
(17) and ligation of the prostate blood supply (18).
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Estrogen administration reduces the size of the prostate
temporarily but can lead to bone marrow suppression and
squamous metaplasia of the prostate, causing ductal
obstruction with retention cyst formation. Thus, its use is
limited to valuable breeding dogs (12,13). Alpha-1
adrenoceptor antagonists (14) have been found to be
useful in the treatment of urinary outlet obstruction due
to benign prostate hypertrophy in humans (14) and dogs
(19). These drugs are more important for humans than
for dogs, because BPH does not usually cause outlet
obstruction in dogs, but constipation (6,13). Synthetic
steroids (17) and 5-Alpha reductase aromates (16) have
also been reported to cause significant prostate atrophy
in dogs by causing inhibition of both epithelial and
stromal components. However, prostate enlargement
may relapse later on following the cessation of those
drugs (16,17). Ligation of the prostate blood supply (18)
may not effectively reduce the size and weight of the
prostate.
These treatment methods using drugs cause only
temporarily prostate atrophy and further techniques are
necessary to do this permanently. As described above, the
prostate innervating nerves stimulate the prostate
secretory epithelium, and the dysfunction of these nerves
surgically may cause prostate atrophy permanently for
dogs that do not respond to medical treatment.
Therefore, the current study was designed to induce
prostate atrophy by ligating prostate vessels together
with nerves. We then observed changes in the prostates
histologically to reveal whether ligation has any effect on
prostate atrophy.

Materials and Methods
Animal material consisted of 10 crossbred dogs. Age
of dogs varied from from 2 to 5 (mean 3.4 years) and
body weight varied from 15 to 52 (mean 27 kg). The
prostates of these dogs were revealed to be within the
normal limits of the pelvic canal by rectal palpation.
Surgery
Before anesthesia, the dogs were fasted overnight.
The dogs were placed in dorsal recumbency, and then a
ventral midline incision was performed. The skin incision
was made approximately 3 cm posterior to the umbilicus,
around the prepuce, to the pubic bone; the prepuce was
reflected laterally. The abdominal cavity was entered
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through the linea alba on the midline. Periprostatic fat
was reflected dorsally to either side of the gland to
expose the vasculature and nerve innervation on the
dorsolateral surface of the gland. By rolling the isolated
gland to one side, the bifurcation of the artery was seen.
The prostatic vessels were then ligated doubly with
nonabsorbable suture material (Figure 1). Care was
taken to preserve the caudal artery as it coursed cranially
to supply the trigone area of the urinary bladder. The
hypogastric and pelvic nerves were then identified and
cut. The maximal length and depth on the longitudinal
plane and width on the transverse plane were measured
using a hand calliper. Finally, the midline abdominal
incision was then closed in a routine fashion. Daily
intramuscular antibiotic was administered for 1 week.
The dogs were kept in kennels for 3 months and any
disease related to the urinary tract or other organs was
monitored. No complications were encountered. Three
months post-operation, the dogs were euthanased by an
overdose of sodium pentobarbital (50 mg/kg,
intravenously). Each of the prostate glands was removed
and trimmed of surface fat, peritoneum and loose
connective tissue. The physical dimensions of the glands
were measured.
Prostate weight during surgery and after euthanasia
was also detected using a formula reported previously by
Atalan et al. (10),

Prostate weight (g): 0.628 x (length x width x depth)
– 0.216.
Histopathology
For histopathological examination, 2 hemi-crosssections of each prostate, one from the left mid portion
and another from the right mid portion, were obtained.
These tissues were fixed in 10% neutral buffered
formalin, embedded in paraffin, and then stained with
hematoxylin. Tissues were evaluated under light
microscope at 5, 10 and 40x magnification.
Statistical Analyses
A paired-t test was employed to determine whether
there were significant differences between prostate
dimensions and weight measured during and after
euthanasia using the Minitab computing system
(Pennsylvania State University).

Results
The length, depth and width of prostate measured
during surgery ranged from 2.5 to 4 cm (mean 3.14),
1.8 to 2.8 cm (mean 2.38) and 2.2 to 4.2 cm (mean
2.93), respectively. Physical measurements taken after
euthanasia ranged from 2.2 to 3.7 cm (mean 2.87) for
length, 1.7 to 2.7 cm (mean 2.24) for depth and 2.1 to
4 cm (mean 2.77) for width. There was a significant

Figure 1. Ligation of prostatic vessels.
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difference between the mean prostate length and weight
measured during surgery and after euthanasia (P <
0.05), with a mean difference of 0.27 cm for length and
2.52 g for weight. However, there were no differences in
depth (0.14 cm) and width (0.16 cm) (Table).
The prostate weight measured during surgery ranged
from 6.3 to 29 g with a mean of 13.84 g, whereas after
euthanasia it ranged from 4.5 to 25 g (mean 11.32 g)
(Table).
A small area of necrosis on the dorsal aspect of the
prostate was detected macroscopically in 6 dogs, and
these areas were only located superficially on the prostate
capsule. Interestingly, an anastomosed branch of the
prostate artery was detected in all dogs.
Histopathological Examination
Under microscopic examinations, a generalized
decrease in compound tubular alveolar glands was
detected for all dogs, while an increase in fibrous tissue
formation through the prostates was noted. Mononuclear
inflammatory cells around the acini and necrotic cells in
the tubular lumen were encountered in the prostates.
Acines were observed to be pink when stained (Figure 2).

Discussion
This study indicated that there was a significant
decrease between prostate length and weight measured
during surgery and after euthanasia. However, in clinical
practice, such a decrease is not important enough to

Table.

magnify the atrophy process in cases of enlarged
prostate. That is, the assurance of prostate atrophy may
not be achieved by the ligation of prostate vessels and
nerves. This finding was in agreement with the results of
Kopp and Stockton (18) and Hodson (20) who only
ligated the prostate vessels. Failure to induce prostate
atrophy may be associated with the rapid formation of
anastomosis following ligation. The mean estimated
prostatic weight during surgery and after euthanasia was
13.84 and 11.32 g, respectively. This difference could be
related to glandular tissue impairment through the
prostate. Moreover, a general decrease in the glandular
tubular compound for all dogs may be due to the lack of
sympathetic innervation of the hypogastric and pelvic
nerves. The experimental design in the present study was
planned to run over a 3-month period. Significant
prostate atrophy could occur over a more prolonged
period, but this remains to be proven.
Various methods have been reported for reducing the
prostate size in dogs including synthetic estrogens,
hormone therapy and prostate-vessel ligation (6,8,9,1220). Ligation of the prostate vessels alone was found to
be ineffective for prostate atrophy (18,20). Hormone
therapy was effective in reducing prostate size; however,
it may cause bone marrow depression when used over the
long term (8,12,13). Therefore, castration seems to be
the method of choice for the treatment of prostate
hyperplasia. However, some owners are opposed to
castration, and therefore further research is required to
develop alternative approaches for reducing prostate size.

Avarage prostate diameters (cm) and weight (g) measured during surgery and after
euthanasia for 10 dogs.
During Surgery
(mean ± sem)

After Euthanasia
(mean ± sem)

Mean Difference
(mean ± sem)

Length

3.14* ± 0.152

2.87* ± 0.151

0.27 ± 0.260

Depth

2.38# ± 0.097

2.24# ± 0.108

0.14 ± 0.120

Width

2.93# ± 0.181

2.77# ± 0.160

0.16 ± 0.049

Prostate Weight

13.84* ± 2.01

11.32* ± 1.78

2.52 ± 0.452

Values represent mean ± SEM (standard error mean)
Statistical analyses were performed by the comparison of prostate dimensions obtained during
surgery and after euthanasia.
#: Not significant
*: P < 0.05 (n = 10).
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Figure 2 Obtained 3 months after ligation of the prostate vessel and nerves. A significant
decrease in compound tubular alveolar glands is notable. Stroma is prominent.
relatively fibroblastic and abundant (arrows).

In conclusion, the present study suggests that ligation
of the prostate vessels and nerves is not the method of
choice for inducing significant prostate atrophy in clinical
practice, although significant differences were obtained
between mean prostate length and weight. The failure

was attributed to the rapid formation of vascularization
around the prostate. A general decrease in glandular
tubular compound might be due to the absent nerve
innervations responsible for glandular secretion.
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